INVO Bioscience signs JV agreement with Medesole Healthcare
India, Jan. 17 -- US based INVO Bioscience, Inc., a medical device company focused on treating infertility with its FDA-cleared INVOcell(R) product, and Qatar based Medesole, a leading supplier of healthcare products inIndiaand theMiddle East, have announced the signing of a joint venture to operate dedicated INVOcell clinics inIndia.
INVOcell, also known as IVC, is the world's onlyin vivoIntravaginal Culture System, offering patients diagnosed with infertility an effective solution through a simplified, more natural and less costly process than traditional in-vitro fertilization (IVF).
The new joint venture (JV) will operate under the name Medesole INVO Bioscience Private Limited. Under terms of the agreement, INVO Bioscience and Medes...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.